ENTITY
Grifols SA

Grifols SA (GRF SM)

67
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishGrifols SA
16 Feb 2023 18:58

Liquid Universe of European Ordinary and Preferred Shares: February ‘23 Report

Since mid-January, spreads have generally tightened across our liquid universe (8 have widened, 10 tightened, 1 at same level).

Share
bearishGrifols SA
16 Nov 2022 23:03

Liquid Universe of European Ordinary and Preferred Shares: November ‘22 Report

Since mid-September, spreads have shown a mixed performance across our liquid universe with a slight bias towards widening (10 have widened, 8...

Share
bullishGrifols SA
17 Oct 2022 12:52

Liquid Universe of European Ordinary and Preferred Shares: October ‘22 Report

Since mid-September, spreads have shown a mixed performance across our liquid universe with a slight bias towards widening.

Share
bearishGrifols SA
17 Sep 2022 00:02

Liquid Universe of European Ordinary and Preferred Shares: September ‘22 Report

Since mid-August, spreads have shown a mixed performance across our liquid universe with a slight bias towards tightening (with the exception of...

Share
bearishBiotest AG
28 Jan 2022 17:05

Grifols/Biotest: Put Period

At the end of the additional offer acceptance period, Grifols has 96.2% of the voting rights and holds 69.72% of the share capital of Biotest. The...

Share
x